FDA Spinal Disc Draft Guidance Under Development; AAOS Weighs In
This article was originally published in The Gray Sheet
Executive Summary
FDA's planned draft guidance on preclinical and clinical trial design for spinal disc replacement systems might draw on a FDL-1proposed guidance developed by the American Association of Orthopaedic Surgeons